Programme
|
10:00-10:15
|
|
Opening
Prof. Roman Hájek
|
|
10:15-11:00
|
|
Highlights from ASH on Multiple Myeloma
Prof. Paul Richardson
|
|
11:00-11:15
|
|
Break
|
|
11:15-12:00
|
|
Benefits of continuous treatment in Multiple Myeloma
Prof. Paul Richardson
|
|
12:00-13:00
|
|
Lunch
|
|
13:00-14:30
|
|
Practical recommendations for use of IMiDs in relapsed / refractory Multiple Myeloma
|
|
14:30-15:30
|
|
Break
|
|
15:30-16:30
|
|
Common cooperation in study CMG 2008
Prof. Roman Hájek
|
|
16:30-17:00
|
|
Closing remarks
Prof. Roman Hájek
|
|
19:00
|
|
Dinner
|
|
Ladies and gentlemen, dear colleagues,
Since 2009, we have been able to offer therapeutic regimes with lenalidomide (Revlimid) also to our patients in the Czech Republic, Slovak Republic and Slovenia. I am very glad that the workshop of Celgene company was dedicated exactly to this drug.
I believe that the 1st International Multiple Myeloma workshop was the best step and benefit on the way of optimization of the use of lenalidomide in our conditions.
Thank you very much for your active and lively participation in the discussion and I thank Celgene company for sponsorship of this meeting.
On behalf of CMG
Roman Hájek
|
